OPEN END TURBO PUT WARRANT - ELI LILLY & CO | Delayed Deutsche Boerse AG 07:41:09 2024-07-02 EDT | ||
| 5.77 EUR | +3.41% |
|
| Current month | -4.94% | ||
| 1 month | -62.04% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-07-02 | 5.77 | +3.41% |
| 24-07-01 | 5.58 | -4.94% |
| 24-06-28 | 5.87 | -10.79% |
| 24-06-27 | 6.58 | -6.67% |
| 24-06-26 | 7.05 | +5.22% |
Delayed Quote Deutsche Boerse AG
Last update July 02, 2024 at 07:41 am
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | UBS |
| WKN | UM2B68 |
| ISIN | DE000UM2B682 |
| Date issued | 2024-02-06 |
| Strike | 973.7 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 28.48 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 24.99 € |
|---|---|
| Lowest since issue | 5.25 € |
| Spread | 0.3 € |
| Spread % | 4.94% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
914.4
USD
Average target price
868.9
USD
Spread / Average Target
-4.97%
- Stock Market
- Certificates
- Certificat
